- $5.26bn
- $5.65bn
- €1.19bn
Brief: Stevanato Group S.p.A. Sees FY adjusted EPS EUR 0.58-0.62
Stevanato Group SpA expected to post earnings of 13 cents a share - Earnings Preview
Stevanato Group SpA reports results for the quarter ended in March - Earnings Summary
Brief: Stevanato Group SpA - Reiterates Full Year 2023 Guidance
Stevanato Group SpA expected to post earnings of 12 cents a share - Earnings Preview
Brief: Stevanato Group Secures €130 Mln ESG-Linked Financing
Stevanato Group SpA reports results for the quarter ended in December - Earnings Summary
Brief: Stevanato Group Q4 Revenue Increased 26%
Stevanato Group SpA expected to post earnings of 16 cents a share - Earnings Preview
Stevanato Group SpA reports results for the quarter ended in September - Earnings Summary
Stevanato Group SpA expected to post earnings of 13cents a share - Earnings Preview
Brief: Stevanato Group, DWK Life Sciences Sign Non-Exclusive Distribution Agreement
Brief: Conestoga Capital Advisors Reports 10.65% Passive Stake In Stevanato Group
Brief: Stevanato Group And Gerresheimer AG Announce Collaboration On The Development Of An Innovative Ready-To-Use Vial Platform For The Pharmaceutical Industry
Brief: Gerresheimer And Stevanato Group Announce Collaboration On Innovative Ready-To-Use Vial Platform
Brief: Stevanato Group SpA Q2 Diluted Earnings Per Share 0.12 EUR
Brief: Stevanato Group Adding New Capacity In Italy Amid Growing Demand For Its Market-Leading Solutions
Brief: Stevanato Group SPA Q1 Revenue Rose 10 Percent To 212.1 Million EUR
Brief: Stevanato Group S.p.A., Bexson Biomedical Expand Collaboration